Article
Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.
The Journal of antimicrobial chemotherapy - 1 Apr 2005
Hidri Nadia, Barnaud Guilène, Decré Dominique, Cerceau Claude, Lalande Valérie, Petit Jean Claude, Labia Roger, Arlet Guillaume
Abstract excerpt
OBJECTIVES: The aim of this study was to characterize the ampC beta-lactamase gene of a clinical isolate of Serratia marcescens resistant to ceftazidime. METHODS: S. marcescens SMSA was isolated from an intra-abdominal wound of a patient previously treated with ceftazidime. A susceptible strain, SLS73, was used as a control. Susceptibility testing, PCR, DNA sequencing, molecular cloning, site-directed mutagenesis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
